110 related articles for article (PubMed ID: 16524561)
1. Pharmacological characterization of protease activated receptor-1 by a serum responsive element-dependent reporter gene assay: major role of calmodulin.
De Vries L; Palmier C; Finana F; Le Grand B; Perez M; Cussac D
Biochem Pharmacol; 2006 May; 71(10):1449-58. PubMed ID: 16524561
[TBL] [Abstract][Full Text] [Related]
2. Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways.
Notcovich C; Diez F; Tubio MR; Baldi A; Kazanietz MG; Davio C; Shayo C
Exp Cell Res; 2010 Feb; 316(3):401-11. PubMed ID: 19913013
[TBL] [Abstract][Full Text] [Related]
3. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
Watts VL; Motley ED
Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
[TBL] [Abstract][Full Text] [Related]
4. Activation of serum response element by D2 dopamine receptor is governed by Gbetagamma-mediated MAPK and Rho pathways and regulated by RGS proteins.
Ho G; Wang Y; Jones PG; Young KH
Pharmacology; 2007; 79(2):114-21. PubMed ID: 17179741
[TBL] [Abstract][Full Text] [Related]
5. Signaling mechanisms involved in protease-activated receptor-1-mediated interleukin-6 production by human gingival fibroblasts.
Tanaka N; Morita T; Nezu A; Tanimura A; Mizoguchi I; Tojyo Y
J Pharmacol Exp Ther; 2004 Nov; 311(2):778-86. PubMed ID: 15210834
[TBL] [Abstract][Full Text] [Related]
6. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors.
Hains MD; Wing MR; Maddileti S; Siderovski DP; Harden TK
Mol Pharmacol; 2006 Jun; 69(6):2068-75. PubMed ID: 16554409
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor 1 antagonists prevent platelet aggregation and adhesion without affecting thrombin time.
Nadal-Wollbold F; Bocquet A; Bourbon T; Létienne R; Le Grand B
Eur J Pharmacol; 2010 Oct; 644(1-3):188-94. PubMed ID: 20655904
[TBL] [Abstract][Full Text] [Related]
8. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
Martin CB; Mahon GM; Klinger MB; Kay RJ; Symons M; Der CJ; Whitehead IP
Oncogene; 2001 Apr; 20(16):1953-63. PubMed ID: 11360179
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay.
Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q
Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170
[TBL] [Abstract][Full Text] [Related]
11. Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signalling.
Stables J; Scott S; Brown S; Roelant C; Burns D; Lee MG; Rees S
J Recept Signal Transduct Res; 1999; 19(1-4):395-410. PubMed ID: 10071773
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway.
Chiu YC; Fong YC; Lai CH; Hung CH; Hsu HC; Lee TS; Yang RS; Fu WM; Tang CH
Mol Immunol; 2008 Mar; 45(6):1587-99. PubMed ID: 18062909
[TBL] [Abstract][Full Text] [Related]
13. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Yamakado T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism.
Di Serio C; Pellerito S; Duarte M; Massi D; Naldini A; Cirino G; Prudovsky I; Santucci M; Geppetti P; Marchionni N; Masotti G; Tarantini F
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):63-9. PubMed ID: 17577318
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.
Al-Ani B; Saifeddine M; Kawabata A; Renaux B; Mokashi S; Hollenberg MD
J Pharmacol Exp Ther; 1999 Aug; 290(2):753-60. PubMed ID: 10411588
[TBL] [Abstract][Full Text] [Related]
16. Cyclic-AMP response element-based signaling assays for characterization of Trk family tyrosine kinases modulators.
Zhang J; Chen D; Gong X; Ling H; Zhang G; Wood A; Heinrich J; Cho S
Neurosignals; 2006-2007; 15(1):26-39. PubMed ID: 16837782
[TBL] [Abstract][Full Text] [Related]
17. Rat leucine-rich protein binds and activates the promoter of the beta isoform of Ca2+/calmodulin-dependent protein kinase II gene.
Ochiai N; Masumoto S; Sakagami H; Yoshimura Y; Yamauchi T
Neurosci Res; 2007 May; 58(1):67-76. PubMed ID: 17339062
[TBL] [Abstract][Full Text] [Related]
18. Cyclic adenosine 3',5'monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells.
Harada T; Kanasaki H; Mutiara S; Oride A; Miyazaki K
Biol Reprod; 2007 Oct; 77(4):707-16. PubMed ID: 17596563
[TBL] [Abstract][Full Text] [Related]
19. Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.
Rosenkranz AC; Rauch BH; Freidel K; Schrör K
Cardiovasc Res; 2009 Sep; 83(4):778-84. PubMed ID: 19460777
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase additively activates the mouse Per1 gene promoter with CaM kinase II.
Nomura K; Takeuchi Y; Fukunaga K
Brain Res; 2006 Nov; 1118(1):25-33. PubMed ID: 17020748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
